BioWorld MedTech

April 23, 2012

FDA clears Abbott's iFS laser for cataract surgery

Abbott (Abbott Park, Illinois) reported FDA clearance to use its iFS advanced femtosecond laser to create bow-shaped or curved arcuate incisions in corneal surgery, including cataract surgery. Read More

Report from Israel: Tortuous path seen from research to clinic for personalized medicine

Report from Europe: PIP implant failures significantly higher than previously thought

Washington roundup: FDA reposts warning letter months after initial posting

Agreements/contracts: HearPo reveals plan to offer discounted hearing care services

MDD's Fun Facts

Court report: Zeltiq successful in false claims claims case of its cooling system

Restructuring roundup: MAI in plan to realign 3 strategic business units

Patent watch: CLS receives patent for translation risk management

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 22, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...